(Q53658088)

16 May 2018

title

Successful allogeneic hematopoietic stem cell transplantation using triple agent immunosuppression in severe aplastic anemia patients. (English)

1 reference

16 May 2018

1 reference

1 reference

Kim HJ

1

1 reference

16 May 2018

Park CY

2

1 reference

16 May 2018

Park YH

3

1 reference

16 May 2018

Kim YJ

4

1 reference

16 May 2018

Kim DW

5

1 reference

16 May 2018

Min WS

6

1 reference

16 May 2018

Kim CC

7

1 reference

16 May 2018

language of work or name

English

0 references

publication date

1 January 2003

1 reference

16 May 2018

Bone Marrow Transplantation

published in

1 reference

16 May 2018

volume

31

1 reference

16 May 2018

issue

2

1 reference

16 May 2018

page(s)

79-86

1 reference

16 May 2018

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1703786

exact match

0 references

cites work

Treatment of aplastic anaemia by antilymphocyte globulin with and without allogeneic bone-marrow infusions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703786

Successful retransplantation of bone marrow following failure of initial engraftment in a patient with aplastic anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703786

The modern management of severe aplastic anaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703786

Cyclophosphamide and antithymocyte globulin to condition patients with aplastic anemia for allogeneic marrow transplantations: the experience in four centers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703786

The pathophysiology of acquired aplastic anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703786

Current results of bone marrow transplantation in patients with acquired severe aplastic anemia. Report of the European Group for Blood and Marrow transplantation. On behalf of the Working Party on Severe Aplastic Anemia of the European Group for Bl

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703786

7 January 2021

Autoimmunity and its treatment in aplastic anemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703786

7 January 2021

High-dose peripheral blood stem cell transplant for multitransfused severe aplastic anaemia patients without antithymocyte globulin in the conditioning regimen

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703786

7 January 2021

Engraftment of marrow allografts treated with Campath-1 monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703786

7 January 2021

Late graft failure 8 years after first bone marrow transplantation for severe acquired aplastic anemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703786

7 January 2021

Additional stem cell therapy for graft failure after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703786

7 January 2021

Supplemental peripheral blood stem cells to decrease marrow rejection in adult patients with severe aplastic anemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703786

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1703786

1 reference

16 May 2018

Dimensions Publication ID

1014429359

0 references

1 reference

16 May 2018